| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
9,000,000 |
| Market
Cap: |
25.92(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.5962 - $4.7 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kiora Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing products for treating disorders of the eye. Co.'s key product in clinical development is the EyeGate Ocular Bandage Gel, a topically applied eye drop formulation of modified hyaluronic acid (HA). HA is a naturally occurring polymer that is used in various physiological processes, including wound healing, hydration, tissue homeostasis, and joint lubrication. Co. modifies the HA through chemical cross-linking, which allows it to adhere to the ocular surface providing protection and lubrication for the treatment of corneal wounds, defects, and epitheliopathies.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
12,500 |
22,291 |
| Total Buy Value |
$0 |
$0 |
$46,445 |
$95,206 |
| Total People Bought |
0 |
0 |
5 |
8 |
| Total Buy Transactions |
0 |
0 |
5 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Strem Brian M. |
President and CEO |
• • – |
2025-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,941 |
46,103 |
|
- |
|
| Tosca Melissa |
CFO |
• – – |
2025-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,772 |
21,371 |
|
- |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2025-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,772 |
26,375 |
|
- |
|
| Stengone Carmine N. |
Director |
– • – |
2024-09-11 |
4 |
B |
$3.68 |
$4,600 |
D/D |
1,250 |
1,250 |
2.31 |
8% |
|
| Shapiro Aron |
Director |
– • – |
2024-09-10 |
4 |
B |
$3.60 |
$10,800 |
I/I |
3,000 |
3,000 |
2.1 |
14% |
|
| Walters-Hoffert Lisa |
Director |
– • – |
2024-08-19 |
4 |
B |
$3.86 |
$4,825 |
D/D |
1,250 |
1,250 |
2.31 |
-17% |
|
| Tyle Praveen |
Director |
– • – |
2024-08-19 |
4 |
B |
$3.96 |
$19,800 |
D/D |
5,000 |
5,014 |
2.39 |
-17% |
|
| Tosca Melissa |
CFO |
• – – |
2024-08-14 |
4 |
B |
$3.21 |
$6,420 |
D/D |
2,000 |
13,599 |
2.74 |
5% |
|
| Tosca Melissa |
CFO |
• – – |
2024-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,620 |
11,599 |
|
- |
|
| Strem Brian M. |
President and CEO |
• • – |
2024-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,629 |
30,160 |
|
- |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2024-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,355 |
18,577 |
|
- |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2024-06-14 |
4 |
B |
$5.29 |
$7,570 |
D/D |
1,431 |
11,222 |
2.74 |
-32% |
|
| Tosca Melissa |
EVP Finance |
• – – |
2024-06-14 |
4 |
B |
$5.25 |
$525 |
D/D |
100 |
3,979 |
2.66 |
-32% |
|
| Strem Brian M. |
President and CEO |
• • – |
2024-06-13 |
4 |
B |
$5.00 |
$14,997 |
D/D |
3,000 |
14,531 |
2.81 |
-27% |
|
| Parsons Erin |
Director |
– • – |
2024-06-13 |
4 |
B |
$4.88 |
$25,669 |
I/I |
5,260 |
5,260 |
2.1 |
-27% |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
88,338 |
|
- |
|
| Strem Brian M. |
President and CEO |
• • – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
103,783 |
|
- |
|
| Tosca Melissa |
EVP Finance |
• – – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
34,900 |
|
- |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,600 |
25,838 |
|
- |
|
| Strem Brian M. |
President and CEO |
• • – |
2023-03-03 |
4 |
A |
$3.83 |
$59,748 |
D/D |
15,600 |
28,783 |
|
- |
|
| Tosca Melissa |
EVP Finance |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
7,400 |
|
- |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2022-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,238 |
|
- |
|
| Strem Brian M. |
President and CEO |
• • – |
2022-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
13,183 |
|
- |
|
| Tosca Melissa |
EVP of Finance |
• – – |
2022-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
D |
$0.69 |
$75 |
D/D |
(108) |
22,746 |
|
- |
|
288 Records found
|
|
Page 1 of 12 |
|
|
0.02 (0.69%) 
